* Correspondence: Xiaodong Zhao, Children‘s Hospital of Chongqing Medical University, Chongqing, China Disclaimer: All claims expressed in this article are solely those of the authors and do not ...

Sugemalimab with chemotherapy showed a superior long-term overall survival benefit compared with placebo with chemotherapy, as a first-line treatment for patients with NSCLC with no known sensitising ...

Anlotinib plus penpulimab significantly improved progression-free survival and overall survival versus sorafenib in unresectable HCC and might be a new first-line option. These findings require ...

The Second Affiliated Hospital of Anhui Medical University, Anhui Medical University, Hefei, Anhui 230032, China The First Affiliated Hospital of Bengbu Medical University, Bengbu Medical University, ...

Metabolic dysfunction-associated steatotic liver disease (MASLD), affecting approximately 30% of the global population, represents a spectrum of liver disorders ranging from simple steatosis to ...

Department of Interventional Radiology, The Second Affiliated Hospital of Soochow University, Suzhou 215004, China Institute of Functional Nano & Soft Materials (FUNSOM), Jiangsu Key Laboratory for ...

Acute hepatitis E (AHE) in the elderly can lead to severe complications including liver failure and mortality, yet the epidemiological landscape remains poorly characterized. This study aimed to ...

Jing Jue Hua, Department of Orthopaedics, The Second Affiliated Hospital of Anhui Medical University, Hefei, China Disclaimer: All claims expressed in this article are solely those of the authors and ...

Intravenous thrombolysis remains a standard treatment for acute ischemic stroke within 4.5 hours after onset. Vascular reocclusion may occur after intravenous thrombolysis and may be preventable wi ...